Search Results - Huber, Henriette

Henriette Huber

Henriette Huber is a Hungarian sprint canoer who competed in the late 1980s and early 1990s. She won two silver medals in the K-4 500 m event at the ICF Canoe Sprint World Championships, earning them in 1989 and 1990. Provided by Wikipedia
  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    End point surrogacy in first-line chronic lymphocytic leukemia by Simon, Florian (Author) , Ligtvoet, Rudy (Author) , Robrecht, Sandra (Author) , Cramer, Paula (Author) , Kutsch, Nadine (Author) , Fürstenau, Moritz (Author) , Goede, Valentin (Author) , Tresckow, Julia von (Author) , Langerbeins, Petra (Author) , Fink, Anna-Maria (Author) , Huber, Henriette (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Wendtner, Clemens M. (Author) , Ritgen, Matthias (Author) , Dreyling, Martin (Author) , Müller, Lothar (Author) , Jacobasch, Lutz (Author) , Heinz, Werner J. (Author) , Vehling-Kaiser, Ursula (Author) , Sivcheva, Liliya (Author) , Böttcher, Sebastian (Author) , Dreger, Peter (Author) , Illmer, Thomas (Author) , Gregor, Michael (Author) , Staber, Philipp B. (Author) , Stilgenbauer, Stephan (Author) , Niemann, Carsten U. (Author) , Kater, Arnon P. (Author) , Fischer, Kirsten (Author) , Eichhorst, Barbara (Author) , Hallek, Michael (Author) , Al-Sawaf, Othman (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:
  2. 2
    Cover Image

    Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut by Huber, Henriette (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Edenhofer, Simone (Author) , Tresckow, Julia von (Author) , Robrecht, Sandra (Author) , Giza, Adam (Author) , Zhang, Can (Author) , Fürstenau, Moritz (Author) , Dreger, Peter (Author) , Ritgen, Matthias (Author) , Illmer, Thomas (Author) , Illert, Anna Lena (Author) , Dürig, Jan (Author) , Böttcher, Sebastian (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:
  3. 3
    Cover Image

    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia by Huber, Henriette (Author) , Edenhofer, Simone (Author) , von Tresckow, Julia (Author) , Robrecht, Sandra (Author) , Zhang, Can (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Bloehdorn, Johannes (Author) , Fürstenau, Moritz (Author) , Dreger, Peter (Author) , Ritgen, Matthias (Author) , Illmer, Thomas (Author) , Illert, Anna L. (Author) , Dürig, Jan (Author) , Böttcher, Sebastian (Author) , Niemann, Carsten U. (Author) , Kneba, Michael (Author) , Fink, Anna-Maria (Author) , Fischer, Kirsten (Author) , Döhner, Hartmut (Author) , Hallek, Michael (Author) , Eichhorst, Barbara (Author) , Stilgenbauer, Stephan (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:

Search Tools: